Funding search · EIN 366975534 · Dallas, TX

Dr Ralph & Marian Falk Medical Research Tr

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

141
grants reported
$32.5M
total given
2021–2024
filing years
$175,864
median grant

Based on grants this organization reported to the IRS for tax years 20212024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

developtherapycelltargetingnovelantidevelopmentcancer

Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

0 grants matching “arthritis and autoimmune disease

No grants to show here.

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

  • Medical College of Wisconsin6 grants · $2.6M
  • Cleveland Clinic Foundation8 grants · $2.5M
  • Yale University School of Medicine7 grants · $2.0M
  • Indiana University9 grants · $2.0M
  • Case Western Reserve University8 grants · $1.9M
  • Childrens Hospital Medical Center5 grants · $1.8M
  • Regents of University of Michigan6 grants · $1.7M
  • University of Cincinnati8 grants · $1.6M
  • University of Minnesota9 grants · $1.5M
  • Brown University of Providence5 grants · $1.5M

Giving over time

$8.4M
2021
$8.0M
2022
$7.8M
2023
$8.3M
2024

Grant history

The 100 largest of 141 grants.

  • $1.2M

    Medical College of Wisconsin · Milwaukee, WI · 2021

    Research for chronic pain;

  • $1.1M

    Childrens Hospital Medical Center · Cincinnati, OH · 2021

    Research for parkinsons,

  • $1.1M

    Cleveland Clinic Foundation · Cleveland, OH · 2021

    Glioblastoma treatments &

  • $1.1M

    Yale University School of Medicine · New Haven, CT · 2021

    Develope cancer vaccines;

  • $869,930

    Regents of University of Michigan · Pittsburgh, PA · 2021

    Device to predict

  • $504,854

    Brown University of Providence · Providence, RI · 2022

    Anti-malaria drugs targetng

  • $497,018

    University of Cincinnati · Cleveland, OH · 2023

    Inhibitors targeting peanut

  • $495,146

    Brown University of Providence · Providence, RI · 2023

    Anti-malaria drugs targetng

  • $460,000

    Stanford University · Menlo Park, CA · 2021

    Biomarkers for immune

  • $445,923

    Indiana University · Bloomington, IN · 2022

    Targeting peanut-specific

  • $400,000

    Michigan State University · East Lansing, MI · 2021

    Novel rxr agonist for

  • $377,004

    Medical College of Wisconsin · Milwaukee, WI · 2023

    New drugs to treat

  • $355,809

    Case Western Reserve University · Cleveland, OH · 2024

    Immunotherapy for b cell

  • $348,252

    Yale University - School of Medicine · New Haven, CT · 2024

    Making cancer cells look

  • $346,469

    Medical College of Wisconsin Sen Neuron · Milwaukee, WI · 2022

    Development of sensory

  • $343,159

    Case Western Reserve University · Cleveland, OH · 2023

    B cell cancer therapy using

  • $340,879

    Indiana University · Bloomington, IN · 2024

    Pim2 modulator-multiple

  • $336,255

    Cleveland Clinic Foundation · Cleveland, OH · 2023

    Development of new drug for

  • $334,583

    Medical College of Wisconsin · Milwaukee, WI · 2024

    Pain therapy - sensory

  • $333,333

    Thomas Jefferson University · Philadelphia, PA · 2024

    Protacs for targeting brca

  • $333,333

    Thomas Jefferson University · Philadelphia, PA · 2023

    Protacs for targeting brca

  • $333,333

    Thomas Jefferson University · Philadelphia, PA · 2022

    Protacs for targeting brca

  • $331,974

    Northwestern University · Evanstone, IL · 2022

    T cell thearpy for

  • $331,873

    Cleveland Clinic Foundation · Cleveland, OH · 2024

    Development of new drug for

  • $330,487

    Board Regents of University of Wisconsin · Milwaukee, WI · 2024

    Improve diagnosis of breast

  • $320,000

    Indiana University · Detroit, MI · 2021

    Targeting peanut-specific

  • $318,948

    Medical College of Wisconsin · Milwaukee, WI · 2023

    Development of sensory

  • $315,981

    Medical College of Wisconsin · Milwaukee, WI · 2024

    New drugs to treat

  • $308,897

    Universityof Minnesota · Minneapolis, MN · 2024

    T3 therapy - heart failure

  • $301,032

    Case Western Reserve University · Cleveland, OH · 2022

    B cell cancer therapy using

  • $284,681

    University of Minnesota · Minneapolis, MN · 2024

    Optimized mechanism based

  • $268,735

    University of Chicago · Chicago, IL · 2024

    Metastic lung cancer phase

  • $260,000

    Case Western Reserve University · Cleveland, OH · 2021

    Immunotherapy for b cell

  • $257,044

    Purdue University · West Lafayette, IN · 2024

    Advancing micro rnas as

  • $235,086

    Universityof Minnesota · Minneapolis, MN · 2023

    Thyroid hormone

  • $211,322

    University of Cincinnati · Cleveland, OH · 2022

    Studies for repurposing

  • $210,398

    Northwestern University · Evanston, IL · 2024

    Therapy for chronic kidney

  • $208,319

    University of Iowa · Iowa City, IA · 2024

    Vascular health targeting

  • $204,619

    University of Cincinnati · Cleveland, OH · 2022

    Targeting sexual cycle of

  • $203,837

    University of Minnesota · Minneapolis, MN · 2024

    Systemic bacteremia - host

  • $200,685

    University of Chicago · Chicago, IL · 2023

    Tumor anueploidy -

  • $200,000

    Childrens Hospital Medical Center · Cincinnati, OH · 2022

    Lupus nephritis biomarkers

  • $200,000

    Cleveland Clinic Foundation · Cleveland, OH · 2022

    New weapons to fight

  • $200,000

    Regents of University of Michigan · Ann Arbor, MI · 2022

    Device to predict

  • $200,000

    Yale University School of Medicine · New Haven, CT · 2022

    Targeted degredation of

  • $200,000

    Kumc Ri · Kansas City, KS · 2021

    Eulicidating the role of

  • $200,000

    Northwestern University · Evanstone, IL · 2021

    Neoantigen inducers as

  • $200,000

    Ohio State University · Columbus, OH · 2021

    Optimizingn btk inhibitor

  • $200,000

    Regents of the Univ of Minnesota · Minneapolis, MN · 2021

    Electrical brain circuit

  • $200,000

    Rush University Medical Center · Chicago, IL · 2021

    Anti-hiv antibodies to

  • $200,000

    University of Chicago · Chicago, IL · 2021

    Instatistical design of

  • $200,000

    University of Iowa Research Foundation · Iowa City, IA · 2021

    Piezoelectric immunosensor

  • $197,879

    Ohio State University · Columbus, OH · 2023

    Develop new therapy for

  • $196,613

    Thomas Jefferson University · Philadelphia, PA · 2022

    Chemokine antagonist for

  • $190,000

    Childrens Hospital Medical Center · Cincinnati, OH · 2023

    Lupus nephritis biomarkers

  • $190,000

    Cleveland Clinic Foundation · Cleveland, OH · 2023

    New weapons to fight

  • $190,000

    Regents of University of Michigan · Ann Arbor, MI · 2023

    Device to predict

  • $190,000

    Yale University School of Medicine · New Haven, CT · 2023

    Targeted degredation of

  • $190,000

    Board Regents of University of Wisconsin · Milwaukee, WI · 2022

    Nanoparticles target

  • $190,000

    Childrens Hospital Medical Center · Cincinnati, OH · 2022

    Develop human liver

  • $190,000

    Stanford University - Development Services · Redwood City, CA · 2022

    Novel therapies - major

  • $187,210

    State University of Iowa · Iowa City, IA · 2023

    Improve hypoxic tumor mgmt

  • $186,955

    Cleveland Clinic Foundation · Cleveland, OH · 2024

    Treatment of complex

  • $181,905

    Mayo Clinic · Rochester, MN · 2023

    In vivo generation of car t

  • $179,775

    Indiana University · Bloomington, IN · 2023

    Traumatic brain injury

  • $178,604

    Ohio State University · Columbus, OH · 2024

    Melanoma onset & recurrence

  • $177,796

    Rehabilitation Institute of Chicago · Chicago, IL · 2023

    Repurpose 5-azacytidine -

  • $177,271

    Indiana University · Bloomington, IN · 2023

    Novel minimally invasive

  • $176,327

    University of Minnesota · Minneapolis, MN · 2024

    Develop il-15 - malaria

  • $176,215

    Stanford University · Stanford, CA · 2023

    Metabolic pausing - organ

  • $175,864

    Shirley Ryan Ability Lab · Chicago, IL · 2024

    Restore diaphragm - nerve

  • $175,575

    Mayo Clinic · Rochester, MN · 2024

    Cd-19 targeted car-msc19 in

  • $175,216

    Washington University · St Louis, MO · 2023

    Zika virus genetic arming-

  • $175,188

    Yale University School of Medicine · New Haven, CT · 2022

    Develop phage therapy to

  • $175,000

    Brown University of Providence · Providence, RI · 2024

    Repurposing clopidogrel to

  • $175,000

    Case Western Reserve University · Cleveland, OH · 2024

    Pharma strategy to treat

  • $175,000

    Loyola University of Chicago · Chicago, IL · 2024

    Inhibitors for triple

  • $175,000

    Michigan State University · East Lansing, MI · 2024

    Develop new odc inhibitors

  • $175,000

    Regents of University of Michigan · Ann Arbor, MI · 2024

    Neuro-cardiac mechanisms of

  • $175,000

    Regents of University of Michigan · Ann Arbor, MI · 2024

    Antibody cns delivery and

  • $175,000

    University of Cincinnati · Cleveland, OH · 2024

    Develop improved method of

  • $175,000

    Washington University · St Louis, MO · 2024

    Stem cell derived islets

  • $175,000

    Board Regents of University of Wisconsin · Milwaukee, WI · 2023

    Diabetes stem cell cure -

  • $175,000

    Brown University of Providence · Providence, RI · 2023

    Repurposing clopidogrel to

  • $175,000

    Case Western Reserve University · Cleveland, OH · 2023

    Blocking peptide treatment

  • $175,000

    Michigan State University · East Lansing, MI · 2023

    Develop new odc inhibitors

  • $175,000

    University of Chicago · Chicago, IL · 2023

    Development of syngap1

  • $175,000

    University of Cincinnati · Cleveland, OH · 2023

    Develop improved method of

  • $175,000

    Board Regents of University of Wisconsin · Milwaukee, WI · 2022

    Diabetes stem cell cure -

  • $175,000

    Case Western Reserve University · Cleveland, OH · 2022

    Blocking peptide treatment

  • $175,000

    University of Chicago · Chicago, IL · 2022

    Development of syngap1

  • $174,784

    Washington University · St Louis, MO · 2022

    Zika virus genetic arming-

  • $174,425

    Mayo Clinic · Rochester, MN · 2023

    Cd-19 targeted car-msc19 in

  • $173,839

    University of Minnesota · Minneapolis, MN · 2024

    Sound waves assessment via

  • $173,785

    Stanford University - Development Services · Redwood City, CA · 2022

    Metabolic pausing - organ

  • $173,769

    Children'S Hospital Medical Center · Cincinnati, OH · 2024

    Autoimmune arthritis

  • $173,717

    Washington University · St Louis, MO · 2024

    Vagus nerve stimulation -

  • $173,673

    University of Minnesota · Minneapolis, MN · 2023

    Develop il-15 - malaria

  • $173,096

    Brown University of Providence · Providence, RI · 2024

    Gene therapy for

  • $173,017

    Yale University School of Medicine · New Haven, CT · 2023

    Develop phage therapy to

View all 141 grants →

Who else funds this kind of work

Same state

Similar purposes

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.